MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2013 budget resolution. H. Con.Res 112, Establishing the budget for the US Government for FY 2013 H.R. 5973/S.2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JOHN FUSSARO | — |
| AARTI SHAH | — |
Health Issues HCR
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2012 (implemention).
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JOHN FUSSARO | — |
| AARTI SHAH | — |
Pharmacy PHA
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JOHN FUSSARO | — |
| AARTI SHAH | — |
Medicare/Medicaid MMM
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JOHN FUSSARO | — |
| AARTI SHAH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.